Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
40,198
Total Claims
$3.7M
Drug Cost
6,711
Beneficiaries
$548
Cost/Patient
Risk Score Breakdown 12/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
-53%
Cost per patient vs peers
$548 vs $1,174 avg
+20%
Brand preference vs peers
10.7% vs 8.9% avg
Brand vs Generic
Brand: 4,239 claims · $2.8M
Generic: 35,524 claims · $872K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Dulaglutide | 254 | $422K |
| Apixaban | 350 | $366K |
| Rivaroxaban | 124 | $151K |
| Empagliflozin | 107 | $144K |
| Sitagliptin Phosphate | 99 | $138K |
| Fluticasone Propion/Salmeterol | 114 | $108K |
| Semaglutide | 71 | $106K |
| Budesonide/Formoterol Fumarate | 111 | $68K |
| Insulin Aspart | 55 | $65K |
| Atorvastatin Calcium | 3,390 | $65K |
| Dapagliflozin Propanediol | 43 | $61K |
| Umeclidinium Bromide | 56 | $50K |
| Umeclidinium Brm/Vilanterol Tr | 59 | $48K |
| Rosuvastatin Calcium | 947 | $46K |
| Insulin Degludec | 52 | $46K |
Prescribing Profile
Patient Profile
72
Avg Age
61%
Female
1.23
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data